The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-09-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203793PMID 10980621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methyltransferase Dnmt1 associates with histone deacetylase activity

  2000cited by this paper
• The BRCA2 transactivation domain does not interact with JNK

  1999cited by this paper
• A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.

  1998cited by this paper
• Involvement of Brca2 in DNA repair.

  1998cited by this paper
• BRCA2 associates with acetyltransferase activity when bound to P/CAF

  1998cited by this paper
• The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

  1998cited by this paper
• The BRCA2 gene product functionally interacts with p53 and RAD51.

  1998cited by this paper
• RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein.

  1997cited by this paper
• Transcriptional activation functions in BRCA2

  1997cited by this paper
• RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 *

  1997cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene.

  1997cited by this paper
• Brca2 is required for embryonic cellular proliferation in the mouse.

  1997cited by this paper
• The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

  1996cited by this paper
• The CBP co-activator is a histone acetyltransferase

  1996cited by this paper
• Selective interaction of JNK protein kinase isoforms with transcription factors.

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

  1993cited by this paper

• Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer.

  2023cites this paper
• Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer

  2018cites this paper
• The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

  2018cites this paper
• University of Southern Denmark Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer French COVAR group collaborators

  2018cites this paper
• Aalborg Universitet Full in-frame exon 3 skipping of BRCA 2 confers high risk of breast and / or ovarian cancer

  2018cites this paper
• The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

  2018cites this paper
• Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.

  2014cites this paper
• Biological and clinical significance of BRCA2

  2011cites this paper
• An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

  2011cites this paper
• Avaliação da patogenicidade de mutações germinativas de significado desconhecido nos genes BRCA1 e BRCA2 em famílias portuguesas.

  2011cites this paper
• Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2

  2010cites this paper
• Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice‐site prediction programs

  2009cites this paper
• Therapeutic exploitation of tumor cell defects in homologous recombination.

  2008cites this paper
• Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases

  2006cites this paper
• Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment.

  2005cites this paper
• Quelle place tiennent les gènes BRCA1 et BRCA2 dans les risques héréditaires de cancer de l’ovaire?

  2005cites this paper
• Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.

  2004cites this paper
• Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression

  2004cites this paper
• M Phase-specific Phosphorylation of BRCA2 by Polo-like Kinase 1 Correlates with the Dissociation of the BRCA2-P/CAF Complex*

  2003cites this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cites this paper
• BRCA2 and pancreatic cancer

  2002cites this paper
• Highlight: BRCA1 and BRCA2 proteins in breast cancer

  2002influential citation
• BRCA2: a genetic risk factor for breast cancer.

  2002cites this paper
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001cites this paper
• Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice

  2001cites this paper
• Chromosome stability, DNA recombination and the BRCA2 tumour suppressor.

  2001cites this paper